GK PHARMA ApS: Financial statements 2012
CVR: 81267316
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 7,684,705 and a net result of DKK 29,961. The profit margin was 0.4%. Equity in the 2012 report amounted to DKK 258,095. The solvency ratio was 9.4%.
- Revenue
- DKK 7,684,705
- Gross Profit
- DKK 2,444,997
- Profit/Loss
- DKK 29,961
- Equity
- DKK 258,095
- Total Assets
- DKK 2,732,617
Official annual report
Keep an eye on GK PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 1, 2012, Andrew John Reks Jacobsen has joined the board of directors of GK PHARMA ApS.
As of August 1, 2012, Klaus Groth has left the board of directors of GK PHARMA ApS.
As of August 1, 2012, Andrew John Reks Jacobsen is registered as director of GK PHARMA ApS.
As of August 1, 2012, Klaus Groth has stepped down as adm. dir. of GK PHARMA ApS.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.